The increasing global prevalence of type 2 diabetes mellitus (T2DM) and chronic kidney
disease (CKD) has prompted research efforts to tackle the growing epidemic of diabetic …

Insights from epidemiological, clinical and basic research are illuminating the interplay
between metabolic disorders, cardiovascular disease (CVD) and kidney dysfunction, termed …

Patients with non-dialysis chronic kidney disease (CKD) are at greater risk of early mortality
and decreased physical function with an advance in the stage of CKD. However, the effect of …

Diabetic kidney disease (DKD) is the leading cause of kidney failure worldwide. Mortality
and morbidity associated with DKD are increasing with the global prevalence of type 2 …

Diabetic nephropathy (DN) is the most important cause of middle and late-stage chronic
kidney disease. Green tea polypeptides are extracted from tea pomace, and exhibit various …

Objective Chronic kidney disease (CKD) is a disabling condition associated with different
medical comorbidities including depression and cognitive impairment. We investigated the …

Introduction Evidence of a direct comparison between dipeptidyl-peptidase 4 inhibitors (DPP-
4is) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) remains lacking, and no clear …

Abstract Background Coreopsis tinctoria Nutt is an ethnomedicine widely used in Xinjiang,
China. It is consumed as a herbal tea by local Uyghur people to treat high blood pressure …

Objective. We aim to identify independent risk factors to predict CKD progression to end
stage renal disease (ESRD) in patients with or without diabetes. Methods. In this …

Polyunsaturated fatty acid (PUFA) intake is generally associated with better renal function,
while the association of monounsaturated fatty acids (MUFAs) remains unconfirmed …